Lanproston

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 559172

CAS#: 105674-77-9

Description: Lanproston is a bioactive chemical.


Chemical Structure

img
Lanproston
CAS# 105674-77-9

Theoretical Analysis

MedKoo Cat#: 559172
Name: Lanproston
CAS#: 105674-77-9
Chemical Formula: C24H31ClO7
Exact Mass: 466.1758
Molecular Weight: 466.95
Elemental Analysis: C, 61.73; H, 6.69; Cl, 7.59; O, 23.98

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: Lanproston;

IUPAC/Chemical Name: (Z)-7-((1R,2R,3R,5S)-2-((E)-2-(2-((3-chlorophenoxy)methyl)-1,3-dioxolan-2-yl)vinyl)-3,5-dihydroxycyclopentyl)hept-5-enoic acid

InChi Key: RWTBSBMVEFAIJX-BOCWSOLPSA-N

InChi Code: InChI=1S/C24H31ClO7/c25-17-6-5-7-18(14-17)30-16-24(31-12-13-32-24)11-10-20-19(21(26)15-22(20)27)8-3-1-2-4-9-23(28)29/h1,3,5-7,10-11,14,19-22,26-27H,2,4,8-9,12-13,15-16H2,(H,28,29)/b3-1-,11-10+/t19-,20-,21+,22-/m1/s1

SMILES Code: O=C(O)CCC/C=C\C[C@@H]1[C@@H](/C=C/C2(COC3=CC=CC(Cl)=C3)OCCO2)[C@H](O)C[C@@H]1O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.03.00

Preparing Stock Solutions

The following data is based on the product molecular weight 466.95 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Ke Y, Gonthier R, Isabelle M, Bertin J, Simard JN, Dury AY, Labrie F. A rapid and sensitive UPLC-MS/MS method for the simultaneous quantification of serum androsterone glucuronide, etiocholanolone glucuronide, and androstan-3α, 17β diol 17-glucuronide in postmenopausal women. J Steroid Biochem Mol Biol. 2015 May;149:146-52. doi: 10.1016/j.jsbmb.2015.02.009. Epub 2015 Feb 18. PubMed PMID: 25701608.

2: Cawley AT, Blakey K, Waller CC, McLeod MD, Boyd S, Heather A, McGrath KC, Handelsman DJ, Willis AC. Detection and metabolic investigations of a novel designer steroid: 3-chloro-17α-methyl-5α-androstan-17β-ol. Drug Test Anal. 2016 Jul;8(7):621-32. doi: 10.1002/dta.1832. Epub 2015 Jun 23. PubMed PMID: 27443417.

3: Ewing L, Brown B. Formation and secretion of 5alpha-androstan-17beta-ol-3-one, 5alpha-androstan-3alpha,17beta-diol and 5alpha-androstan-3beta,17beta-diol by the perfused rabbit testis epididymis. Endocrinology. 1975 Feb;96(2):479-85. PubMed PMID: 1112261.

4: Ahmad MS, Zafar S, Bibi M, Bano S, Atia-Tul-Wahab, Atta-Ur-Rahman, Iqbal Choudhary M. Biotransformation of androgenic steroid mesterolone with Cunninghamella blakesleeana and Macrophomina phaseolina. Steroids. 2014 Apr;82:53-9. doi: 10.1016/j.steroids.2014.01.001. Epub 2014 Jan 22. PubMed PMID: 24462640.

5: Kiousi P, Angelis YS, Fragkaki AG, Abushareeda W, Alsayrafi M, Georgakopoulos C, Lyris E. Markers of mesterolone abuse in sulfate fraction for doping control in human urine. J Mass Spectrom. 2015 Dec;50(12):1409-19. doi: 10.1002/jms.3715. PubMed PMID: 26634976.

6: Smith C, Wahab AT, Khan MS, Ahmad MS, Farran D, Iqbal Choudhary M, Baydoun E. Microbial transformation of oxandrolone with Macrophomina phaseolina and Cunninghamella blakesleeana. Steroids. 2015 Oct;102:39-45. doi: 10.1016/j.steroids.2015.06.008. Epub 2015 Jun 18. PubMed PMID: 26095204.

7: Andrade LC, de Almeida MJ, Paixão JA, Carvalho JF, Sá E Melo ML. 3β,5α,6β-Trihy-droxy-androstan-17-one. Acta Crystallogr Sect E Struct Rep Online. 2011 May 1;67(Pt 5):o1056-7. doi: 10.1107/S1600536811011706. Epub 2011 Apr 7. PubMed PMID: 21754383; PubMed Central PMCID: PMC3089281.

8: Sunde A, Rosness PA, Eik-Nes KB. Metabolism of 5 alpha-androstane-3 beta,17 beta-diol to 17 beta-hydroxy-5 alpha-androstan-3-one and 5 alpha-androstan-3 alpha,17 beta-diol in the rat. Biochim Biophys Acta. 1979 Aug 30;574(2):240-7. PubMed PMID: 39615.

9: Ewing LL. Some factors affecting testosterone, dihydrotestosterone, 5 alpha-androstan-3 alpha,17 beta-diol and 5 alpha-androstan-3 beta,17 beta-diol secretion by invitro perfused rabbit testes. Curr Top Mol Endocrinol. 1975;2:145-64. PubMed PMID: 18320.

10: Fragkaki AG, Angelis YS, Kiousi P, Georgakopoulos CG, Lyris E. Comparison of sulfo-conjugated and gluco-conjugated urinary metabolites for detection of methenolone misuse in doping control by LC-HRMS, GC-MS and GC-HRMS. J Mass Spectrom. 2015 May;50(5):740-8. doi: 10.1002/jms.3583. PubMed PMID: 26259657.

11: Purvis K, Calandra R, Haug E, Hansson V. 5alpha-reduced androgens and testicular function in the immature rat: effects of 5alpha-androstan-17beta-ol-3one (DHT) propionate and 5alpha-androstan-3alpha,17beta-diol. Mol Cell Endocrinol. 1977 May;7(3):203-19. PubMed PMID: 873044.

12: Gómez C, Pozo OJ, Marcos J, Segura J, Ventura R. Alternative long-term markers for the detection of methyltestosterone misuse. Steroids. 2013 Jan;78(1):44-52. doi: 10.1016/j.steroids.2012.10.008. Epub 2012 Nov 2. PubMed PMID: 23127819.

13: Shi R, Zhang CS, Wei K. 16α-Bromo-17β-hydr-oxy-5α-androstan-3β-yl acetate. Acta Crystallogr Sect E Struct Rep Online. 2010 Mar 6;66(Pt 4):o750. doi: 10.1107/S1600536810007555. PubMed PMID: 21580595; PubMed Central PMCID: PMC2983941.

14: Catsoulacos P, Politis D, Boutis L, Papageorgiou A. New compounds: antitumor activity of 3beta-hydroxy-13alpha-amino-13,17-seco-5alpha-androstan-17-oic-13,17-lactam 4-[p-[bis(2-chloroethyl)amino]phenyl]butyrate. J Pharm Sci. 1978 Sep;67(9):1342-3. PubMed PMID: 690853.

15: Chen C, Li X, Singh SM, Labrie F. Activity of 17beta-(N-alkyl/arylformamido) and 17beta-[(N-alkyl/aryl) alkyl/arylamido]-4-methyl-4-aza-5alpha-androstan-3-ones as 5alpha-reductase inhibitors in the hamster flank organ and ear. J Invest Dermatol. 1998 Aug;111(2):273-8. PubMed PMID: 9699729.

16: Pohle HD. [On the tolerance of the liver for 1-alpha-methyl-5-alpha-androstan-17-beta-ol-3-one (mesterolone)]. Arzneimittelforschung. 1966 Apr;16(4):473-4. German. PubMed PMID: 6014253.

17: Kao LW, Crosswell MJ, Weisz J. Steroid metabolism by the lung: conversion of dihydrotestosterone to 5 alpha-androstan-3 alpha, 17 beta-diol by rat lung tissue in vitro. Endocrinology. 1979 Mar;104(3):664-6. PubMed PMID: 436725.

18: Krause W, Jakobs U. Determination of 17 beta-hydroxy-1 alpha-methyl-17 alpha-propyl-5-alpha-androstan-3-one in plasma by gas chromatography-mass spectrometry with single-ion detection. J Pharm Sci. 1984 Apr;73(4):563-4. PubMed PMID: 6726647.

19: ANSFIELD FJ, OLSON KB, RASCH O. The use of androstan-3, 11, dione-17beta-hydroxy, 17-methyl (compound NSC 19605) in the treatment of advanced breast cancer. Cancer. 1962 Mar-Apr;15:330-3. PubMed PMID: 13861731.

20: Thamotharan S, Parthasarathi V, Gupta R, Jindal DP, Linden A. Two azasteroidal [3,2-c]pyrazole derivatives: 2'-(p-fluorophenyl)-4-azapyrazolo[4',3':2,3]-5alpha-androstan-17beta-yl acetate and 2'-(p-fluorophenyl)-4-azapyrazolo[4',3':2,3]-5alpha-androstan-17beta-ol. Acta Crystallogr C. 2003 Dec;59(Pt 12):o724-6. Epub 2003 Nov 30. PubMed PMID: 14671383.